3Z and biotx.ai Forge Partnership to Advance ADHD Drug Development Using AI Modelling
Reykjavik-based drug discovery company, 3Z, and Germany/US-based causal AI firm, biotx.ai, have joined forces in a strategic partnership aimed at revolutionizing ADHD drug development. By leveraging advanced AI modelling techniques, the collaboration seeks to bridge the gap between animal studies and human clinical trials, enabling a more efficient and accurate translation of promising...
Dela artikeln
Taggar: biotxai, forge, partnership
Läs vidare på Dagens Industri